Anti-dengue viral activity of Carica Papaya leaves extract /

Anti-dengue viral activity of Carica Papaya leaves extract /

Show other versions (1)

Bibliographic Details
Main Author:	Siti Latifah Abd. Kadir, author 1987- 527092
Format:	text
Language:	eng
Published:	Johor Bahru, Johor : Universiti Teknologi Malaysia, 2021
Subjects:	Viral vaccines Dengue viruses

Similar Items

Anti-dengue viral activity of Carica Papaya leaves extract /
by: Siti Latifah Abd. Kadir, author 1987- 527092, et al.
Published: (2021)

Molecular identification of dengue virus binding protein on filopodia of vero cells
by: Aliyu, Isah Abubakar
Published: (2017)

Determination of viral factors associated with dengue virus infection and disease severity
by: Suppiah, Jeyanthi
Published: (2019)

Persistence of dengue serotype 2 viral RNA in blood cells of a returned traveler with dengue fever
by: Rebecca S.B. Fischer, et al.
Published: (2024-05-01)

Dengue Vaccines: Current Status and Future Perspectives
by: Vasantha Kamath, et al.
Published: (2024-09-01)

Potency of Carica papaya Leaf Extract as Thrombocytopenia Therapy for Dengue Hemorrhagic Fever: A Systematic Review of Randomized Control Trials
by: Muhammad Farid Firmansyah Sabir, et al.
Published: (2023-03-01)

Co-infection of acute hepatitis A and dengue fever: a case report
by: K. T. Umbetova, et al.
Published: (2022-12-01)

An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2024-08-01)

Frontiers in dengue virus research /
by: Hanley, Kathryn A., editor, et al.
Published: (c201)

Exploring the potential of Carica Papaya Leaf Extract: a perspective on its effectiveness in ameliorating thrombocytopenia in dengue patients
by: Maliha Khalid, et al.
Published: (2025-12-01)

A natural human cell-adapted dengue type 3 virus strain
by: Wy Ching Ng, et al.
Published: (2024-07-01)

Race against dengue
by: Swee Sen Kwek, et al.
Published: (2024-02-01)

Problematic questions in the development of specific prevention of dengue fever
by: E. I. Kazachinskaia, et al.
Published: (2022-03-01)

Dengue virus /
by: Rothman, Alan L., editor
Published: (c201)

A case report on symptomatic disease caused by serotype 4 vaccine virus following tetravalent anti-dengue vaccination
by: Roberto Dias de Oliveira, et al.
Published: (2024-11-01)

Circadian regulation of dengue virus transmission and replication: insights into vector activity and viral dynamics
by: Milad Zandi, et al.
Published: (2024-09-01)

Exploring dengue genome to design effective multi epitope-based peptide vaccine by immunoinformatics approach against all serotypes of dengue virus
by: Md. Sadman Sakib, et al.
Published: (2024-01-01)

Ocular manifestations in patients diagnosed with dengue in a reference hospital in the city of Manaus, Brazil
by: Cláudio do Carmo Chaves Filho, et al.
Published: (2024-06-01)

A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis
by: Mya Myat Ngwe Tun, et al.
Published: (2023-12-01)

Regional molecular epidemiology of dengue and the potential optimization of its control through the use of vaccines. Report of the Arbovirus Committee of the Latin American Society of Pediatric Infectious Diseases, SLIPE
by: Jaime R. Torres, et al.
Published: (2024-12-01)

Protective Mechanisms of <i>Carica papaya</i> Leaf Extract and Its Bioactive Compounds Against Dengue: Insights and Prospects
by: Tanvir Zaman Shoyshob, et al.
Published: (2024-12-01)

Host immunity and vaccine development against Dengue virus
by: Enhao Ma, et al.
Published: (2022-03-01)

CRISPR Screen Reveals PACT as a Pro-Viral Factor for Dengue Viral Replication
by: Shwetha Shivaprasad, et al.
Published: (2024-05-01)

Emergence of Indigenous Dengue Fever, Niger, October 2023
by: Habibatou Idé Amadou, et al.
Published: (2024-07-01)

Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
by: Vannice, Kirsten S., et al.
Published: (2018)

Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 studyResearch in context
by: Alix Miauton, et al.
Published: (2024-01-01)

[IN1438] Dengue and Dengue Virus in Florida
by: Yasmin V. Ortiz, et al.
Published: (2025-02-01)

Enhancing <i>Dengue</i> Virus <i>Production and Immunogenicity</i> with Celcradle™ Bioreactor: A Comparative Study with Traditional Cell Culture Methods
by: Hongxia Guo, et al.
Published: (2024-05-01)

Autochthonous Dengue Fever in 2 Patients, Rome, Italy
by: Serena Vita, et al.
Published: (2024-01-01)

Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells
by: Liao, Kuo-Chieh, et al.
Published: (2024)

Dengue and Other Arbovirus Infections among Schoolchildren, Haiti, 2021
by: Rigan Louis, et al.
Published: (2025-02-01)

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
by: Dominik A. Rothen, et al.
Published: (2024-09-01)

Establishing an in vitro permeability assay to emulate dengue infection /
by: Tan, Kar Ming, 1990-, author, et al.
Published: (2014)

Establishing an in vitro permeability assay to emulate dengue infection /
by: Tan, Kar Ming, 1990-, author
Published: (2014)

Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017)

Dengue encephalitis: A rare manifestation of dengue fever
by: Hewa Babarandage Chathurika Harshani, et al.
Published: (2024-09-01)

Dengue Mimickers: Which Clinical Conditions Can Resemble Dengue Fever?
by: Luis Arthur Brasil Gadelha Farias, et al.
Published: (2024-12-01)

Dengue Virus Serotype 3 Origins and Genetic Dynamics, Jamaica
by: Shanice A. Redman, et al.
Published: (2024-10-01)

Current Dengue Virus Vaccine Developments and Future Directions
by: Govindaraj Anumanthan, et al.
Published: (2025-01-01)

Cross-reactivity and anti-viral function of dengue capsid and NS3-specific memory T cells toward Zika virus
by: Lye, David Chienboon, et al.
Published: (2019)